Literature DB >> 11050454

New agents for Gram-positive bacteria.

S M Bhavnani1, C H Ballow.   

Abstract

Infections caused by multiple-resistant Gram-positive organisms continue to occur at an alarming rate worldwide. Two new and unique antimicrobial agents targeted specifically against such organisms, quinupristin/dalfopristin and linezolid, have been approved for use in the USA in the past year and will play an important role in the treatment of life-threatening infections. In addition, several new fluoroquinolones have been approved recently or will be available in the near future to aid in the treatment of infections caused by resistant strains of Streptococcus pneumoniae.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11050454     DOI： 10.1016/s1369-5274(00)00134-x

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN： 1369-5274            Impact factor:   7.934


  11 in total

Review 1.  New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

Authors:  George G Zhanel; Divna Calic; Frank Schweizer; Sheryl Zelenitsky; Heather Adam; Philippe R S Lagacé-Wiens; Ethan Rubinstein; Alfred S Gin; Daryl J Hoban; James A Karlowsky
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

2.  Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001.

Authors:  Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; Clyde Thornsberry; Daniel F Sahm; James A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.

Authors:  José M Entenza; Jacques Vouillamoz; Michel P Glauser; Philippe Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  Toxicity evaluation of Xanthorrhoea johnsonii leaf methanolic extract using the Artemia franciscana bioassay.

Authors:  I E Cock; F R Kalt
Journal:  Pharmacogn Mag       Date:  2010-07       Impact factor: 1.085

Review 5.  Mechanism of action of and resistance to quinolones.

Authors:  Anna Fàbrega; Sergi Madurga; Ernest Giralt; Jordi Vila
Journal:  Microb Biotechnol       Date:  2008-10-13       Impact factor: 5.813

6.  Pseudomonas aeruginosa inhibits the growth of pathogenic fungi: In vitro and in vivo studies.

Authors:  Lingqing Xu; Feng Wang; Yin Shen; Hongyan Hou; Weiyong Liu; Cailin Liu; Cui Jian; Yue Wang; Mingyue Sun; Ziyong Sun
Journal:  Exp Ther Med       Date:  2014-03-21       Impact factor: 2.447

7.  Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts.

Authors:  Ling-Qing Xu; Jian-Wen Zeng; Chong-He Jiang; Huan Wang; Yu-Zhen Li; Wei-Hong Wen; Jie-Hua Li; Feng Wang; Wei-Jen Ting; Zi-Yong Sun; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

8.  Chemical composition, antibacterial and antifungal activities of essential oil from Cordia verbenacea DC leaves.

Authors:  Fabiola F G Rodrigues; Liana G S Oliveira; Fábio F G Rodrigues; Manuele E Saraiva; Sheyla C X Almeida; Mario E S Cabral; Adriana R Campos; Jose Galberto M Costa
Journal:  Pharmacognosy Res       Date:  2012-07

9.  Anti-nociceptive properties in rodents and the possibility of using polyphenol-rich fractions from sida urens L. (Malvaceae) against of dental caries bacteria.

Authors:  Kiessoun Konaté; Patrice Zerbo; Maurice Ouédraogo; Crépin I Dibala; Hilou Adama; Oksana Sytar; Marian Brestic; Nicolas Barro
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-06-21       Impact factor: 3.944

10.  Antibiotic producing microorganisms from River Wiwi, Lake Bosomtwe and the Gulf of Guinea at Doakor Sea Beach, Ghana.

Authors:  Adelaide A Tawiah; Stephen Y Gbedema; Francis Adu; Vivian E Boamah; Kofi Annan
Journal:  BMC Microbiol       Date:  2012-10-16       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.